Opexa

Opexa Therapeutics Poised For Breakout

Opexa Therapeutics Poised For Breakout

Seeking Alpha

Merck KGaA signs $225 million personalized MS drug deal

Merck KGaA signs $225 million personalized MS drug deal

Pharma Times, UK

Lessons From Biotech's Best Third Quarter Stocks

Lessons From Biotech's Best Third Quarter Stocks

TheStreet.com

Biotechs Treating Incurable Disease Warrant Early Look

Biotechs Treating Incurable Disease Warrant Early Look

Seeking Alpha

Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT

Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT

Wall Street Cheat Street

4 Small-Cap Pharma Stocks With Zero Debt To Consider Currently

4 Small-Cap Pharma Stocks With Zero Debt To Consider Currently

Seeking Alpha

6 Companies That Could Revolutionize Medicine -- And Portfolios

6 Companies That Could Revolutionize Medicine -- And Portfolios

Seeking Alpha

5 Cheap Biotech Stocks That May Rebound Ahead of the Market

5 Cheap Biotech Stocks That May Rebound Ahead of the Market

Seeking Alpha

News

Biotech Stock Mailbag: Best Stocks to Watch in '11

TheStreet.com

News

Opexa soars on talks with FDA over MS drug

Marketwatch